Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 3.8 M4.7 M4.7 M4.7 M5 M6.4 M 20.8 M Research & development —————— — Operating income 39.42 M91.62 M99.29 M94.66 M62.3 M139.36 M 395.61 M Non-Operating Income, Total 1.39 M861 K2.95 M2.9 M3.33 M7.27 M 16.45 M Interest expense, net of interest capitalized 2.54 M2.56 M2.57 M2.98 M3.17 M3.32 M 12.04 M Non-Operating Income, excl. Interest Expenses -1.15 M-1.7 M377 K-81 K165 K3.94 M 4.41 M Unusual income/expense —————— — Pretax income 112.31 M168.29 M178.88 M174.82 M139.66 M219.8 M 713.17 M Equity in earnings —————— — Taxes 23.08 M34.17 M37.23 M36.2 M27.11 M43.93 M 144.47 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 89.23 M134.12 M141.65 M138.62 M112.55 M175.87 M 568.69 M Discontinued operations —————— — Net income 89.23 M134.12 M141.65 M138.62 M112.55 M175.87 M 568.69 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 89.23 M134.12 M141.65 M138.62 M112.55 M175.87 M 568.69 M Basic earnings per share (Basic EPS) 3.855.796.1264.97.73 24.75 Diluted earnings per share (Diluted EPS) 3.835.766.095.974.887.72 24.66 Average basic shares outstanding 23.17 M23.18 M23.16 M23.14 M22.98 M22.76 M — Diluted shares outstanding 23.31 M23.29 M23.27 M23.26 M23.06 M22.79 M — EBITDA 79.31 M135.03 M149 M145.89 M112.21 M193.69 M 600.79 M EBIT 40.08 M91.63 M99.77 M95.16 M62.82 M140.66 M 398.42 M Cost of revenue 272.21 M260.76 M276.39 M263.93 M284.51 M283.94 M 1.11 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 39.23 M43.4 M49.23 M50.73 M49.39 M53.02 M 202.37 M